Mouse models to assess the efficacy of non-typhoidal Salmonella vaccines: Revisiting the role of host innate susceptibility and routes of challenge
- 25 May 2011
- Vol. 29 (32) , 5094-5106
- https://doi.org/10.1016/j.vaccine.2011.05.022
Abstract
No abstract availableKeywords
This publication has 133 references indexed in Scilit:
- Identification by PCR of Non-typhoidal Salmonella enterica Serovars Associated with Invasive Infections among Febrile Patients in MaliPLoS Neglected Tropical Diseases, 2010
- Epidemic multiple drug resistant Salmonella Typhimurium causing invasive disease in sub-Saharan Africa have a distinct genotypeGenome Research, 2009
- Toll‐like receptor 4 signalling through MyD88 is essential to control Salmonella enterica serovar Typhimurium infection, but not for the initiation of bacterial clearanceImmunology, 2009
- Genetic deficiencies of innate immune signalling in human infectious diseaseThe Lancet Infectious Diseases, 2009
- The porin OmpD from nontyphoidal Salmonella is a key target for a protective B1b cell antibody responseProceedings of the National Academy of Sciences, 2009
- Salmonella enterica serovar Typhi live vector vaccines finally come of ageImmunology & Cell Biology, 2009
- Salmonella entericaSerovar Typhimurium Strains with Regulated Delayed Attenuation In VivoInfection and Immunity, 2009
- Conjugation of tetanus toxoid with Salmonella typhimurium PTCC 1735 O-specific polysaccharide and its effects on production of opsonizing antibodies in a mouse modelCanadian Journal of Microbiology, 2005
- Oral Immunization with ATP-Dependent Protease-Deficient Mutants Protects Mice against Subsequent Oral Challenge with VirulentSalmonella entericaSerovar TyphimuriumInfection and Immunity, 2003
- Endotoxin-tolerant Mice Have Mutations in Toll-like Receptor 4 (Tlr4)The Journal of Experimental Medicine, 1999